James Cahill, DPM
Podiatrist · Sumter, SCNPI 1972592491
Payments from drug & device makers
What this record shows
Treace Medical Concepts, Inc. accounts for 79.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $738 and has fallen 50.9% since, to $362 in 2025.
Across 15 payments — averaging $90.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Musculoskeletal Transplant Foundation Inc.$104
- Metric Medical Devices, Inc.$83
- Amgen$45
- Lifenet Health$19
- Stryker$13
- plus $12 from 1 others
Across 1 payment — averaging $1250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Metric Medical Devices, Inc.$1K
What the payments were for
- Travel & lodging$69251%
- Food & beverage$66449%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 7 | $1,080 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $104 |
| Metric Medical Devices, Inc. | 1 | $83 |
| Amgen | 1 | $45 |
| Lifenet Health | 3 | $19 |
| Stryker | 1 | $13 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,356 in reported general payments places this provider in the 55th percentile of 61 podiatrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Colchicine | 12 | $1,404 |
| Diclofenac Sodium | 51 | $945 |
| Gabapentin | 78 | $920 |
| Fluconazole | 56 | $829 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 54 | $825 |
| Doxycycline Hyclate | 69 | $739 |
| Terbinafine Hcl | 33 | $706 |
| Ciclopirox | 40 | $559 |
| Mupirocin | 55 | $478 |
| Amitriptyline Hcl | 41 | $464 |
| Duloxetine Hcl | 16 | $399 |
| Allopurinol | 18 | $351 |
| Ammonium Lactate | 20 | $351 |
| Triamcinolone Acetonide | 41 | $239 |
| Prednisone | 25 | $106 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Sumter
- Brandon PercivalLancaster$136K
- Alan BlockFlorence$96K
- William LongSimpsonville$91K
- Michael McCannFlorence$15K
- Daniel MethuselahIrmo$14K
- Breelyn MilesLadson$13K
- Jeffrey YungHilton Head Island$11K
- Arthur StoneGreenville$11K
- Jamelah LemonMauldin$6K
- Frederick GarlandLongs$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.